Results 111 to 120 of about 7,193 (177)

Lyso-ChR2 activation dynamically regulates autophagy in HEK293T cells.

(a and b) Immunoblotting analysis of the protein levels of LC3-I and LC3-II in HeLa (a) or SH-SY5Y (b) cells transfected with lyso-ChR2 or empty vector. (c) Immunoblotting analysis of LC3-I and LC3-II levels in HEK293T cells stably expressing lyso-NpHR3 ...
Canjun Li (14441919), Qingyan Wang (6730250), Lili Qu (4027688), Ruikun Wu (18430147), Hao Li (31608), Ge Shan (250515), Chunlei Cang (18430150), Bingqian Lin (2553433), Yanan Wei (3768307), Wenping Zeng (3227043), Xingguo Yang (10788921)   +10 more
core   +1 more source

Correction: Assessment of plasma lyso-Gb₃ for clinical monitoring of treatment response in migalastat-treated patients with Fabry disease. [PDF]

Genet Med, 2021
Bichet DG, Aerts JM, Auray-Blais C, Maruyama H, Mehta AB, Skuban N, Krusinska E, Schiffmann R.   +7 more
europepmc   +1 more source

Genetic Modifiers of Cardiac Remodeling Severity in IVS4+919G>A-Associated Fabry Cardiomyopathy. [PDF]

Int J Mol Sci
Sung KT, Hsu CY, Lu YH, Hung CL, Niu DM.
europepmc   +1 more source

Fabry nephropathy as the clinical anchor for kidney-centered metabolic surveillance: linking genetic heterogeneity to early risk identification. [PDF]

Front Genet
Xie Y, Zhong J.
europepmc   +1 more source

Clinical manifestations, diagnosis, and management of renal involvement in Fabry disease. [PDF]

Ren Fail
Guo W, Bi J, Ji P, Xie Y.
europepmc   +1 more source

Fabry Disease: Integrating Molecular Pathophysiology, Precision Diagnosis, and Artificial Intelligence Toward Precision Medicine. [PDF]

Cells
Biddeci G, Spinelli G, Colomba P, Anania M, Duro G, Di Blasi F.   +5 more
europepmc   +1 more source

Impaired motor unit profile in Fabry disease: A quantitative electrophysiological study. [PDF]

Clin Neurophysiol Pract
Gunduz A, Akkan Suzan A, Dinçer MT, Özcan ŞG, Seyahi N.   +4 more
europepmc   +1 more source

The Sphingolipid Balance and Endothelial Dysfunction in Lysosomal Storage Diseases: Shared Mechanisms in Gaucher, Niemann-Pick and Fabry Disease. [PDF]

Int J Mol Sci
Nekrasova A, Kutsev S, Shestopalov A.
europepmc   +1 more source

Genome sequencing reveals the prevalence of Fabry disease-causing variants in Japan: Evidence from the Tohoku Medical Megabank. [PDF]

Genet Med Open
Susukita K, Nochioka K, Takase M, Yamamoto S, Kumada K, Suzuki H, Ohneda K, Noguchi K, Izumi Y, Ogishima S, Nakaya N, Eto Y, Hozawa A, Yasuda S.   +13 more
europepmc   +1 more source

Clinical outcomes of agalsidase Beta (fabrazyme) in Chinese fabry disease patients with proteinuria: a case series. [PDF]

Front Pediatr
He Z, Wu Y, Yang H, Li Y, Xu L.
europepmc   +1 more source